77 related articles for article (PubMed ID: 19864763)
1. Octreotide: a clinical update.
Meier RF; Reichert MM
Saudi J Gastroenterol; 1998 Sep; 4(3):147-55. PubMed ID: 19864763
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
Gyr KE; Meier R
Digestion; 1993; 54 Suppl 1():14-9. PubMed ID: 8103010
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
Gyr KE; Meier R
Metabolism; 1992 Sep; 41(9 Suppl 2):17-21. PubMed ID: 1518430
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
Harris AG
Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues.
Heintges T; Lüthen R; Niederau C
Digestion; 1994; 55 Suppl 1():1-9. PubMed ID: 7907564
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)].
Stöckmann F; Creutzfeldt W
Z Gastroenterol; 1988 Oct; 26(10):665-75. PubMed ID: 2849248
[TBL] [Abstract][Full Text] [Related]
7. Future medical prospects for Sandostatin.
Harris AG
Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
[TBL] [Abstract][Full Text] [Related]
8. [Interaction between gastrointestinal hormones and endocrine regulation].
Pfeiffer EF; Raptis S; Ziegler R
Z Gastroenterol; 1976 Mar; 14 Suppl():70-94. PubMed ID: 8883
[TBL] [Abstract][Full Text] [Related]
9. Octreotide, a new somatostatin analogue.
Katz MD; Erstad BL
Clin Pharm; 1989 Apr; 8(4):255-73. PubMed ID: 2653711
[TBL] [Abstract][Full Text] [Related]
10. [Clinical use of octreotide (Sandostatin) in endocrinology].
Prelević GM
Med Pregl; 1993; 46(9-10):343-8. PubMed ID: 7997211
[TBL] [Abstract][Full Text] [Related]
11. [Use of somatostatin analogue for intestinal and pancreatic fistulas].
Paran H; Neufeld D; Epstein T; Bendahan J; Freund U
Harefuah; 1991 Feb; 120(4):185-6. PubMed ID: 2066018
[TBL] [Abstract][Full Text] [Related]
12. Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide.
Grosman I; Simon D
Am J Gastroenterol; 1990 Sep; 85(9):1061-72. PubMed ID: 1975156
[TBL] [Abstract][Full Text] [Related]
13. Direct proabsorptive effect of octreotide on ionic transport in the small intestine.
Anthone GJ; Bastidas JA; Orandle MS; Yeo CJ
Surgery; 1990 Dec; 108(6):1136-41; discussion 1141-2. PubMed ID: 2247838
[TBL] [Abstract][Full Text] [Related]
14. The role of somatostatin and serotonin in the beta-adrenoceptor regulation of gastric function. An experimental study in dogs.
Bech K
Dan Med Bull; 1988 Apr; 35(2):122-40. PubMed ID: 2896101
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of L-type calcium channels by octreotide in isolated human neuroendocrine tumor cells of the gut.
Glassmeier G; Höpfner M; Riecken EO; Mann B; Buhr H; Neuhaus P; Meyerhof W; Scherübl H
Biochem Biophys Res Commun; 1998 Sep; 250(2):511-5. PubMed ID: 9753663
[TBL] [Abstract][Full Text] [Related]
16. The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review.
Van Op den Bosch J; Adriaensen D; Van Nassauw L; Timmermans JP
Regul Pept; 2009 Aug; 156(1-3):1-8. PubMed ID: 19362110
[TBL] [Abstract][Full Text] [Related]
17. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
Meier R; Dierdorf R; Gyr K
Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptides of the cholecystokinin group: effects and mechanisms of action on the gastro-intestinal and gall bladder motility.
Milenov K; Kalfin R; Todorov S; Raichev P
Acta Physiol Pharmacol Bulg; 1998; 23(3-4):85-91. PubMed ID: 10672334
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
20. Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites.
Grauer L; Barkin JS
Digestion; 1994; 55 Suppl 1():24-8. PubMed ID: 7907566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
